2 weeks ago

Jubilant Ingrevia to Buy 40% Zettaone Stake for ₹189.2 Crore

Jubilant Ingrevia to Buy 40% Zettaone Stake for ₹189.2 Crore
Jubilant Ingrevia to acquire 40% stake in Zettaone Tech for Rs 189.2 crore; bets on semiconductor value-chain · financialexpress.com

Jubilant Ingrevia is a company that mainly makes specialty chemicals.

It plans to buy 40% of Zettaone Technologies India, an electronics engineering and manufacturing company.

The deal will cost ₹189.2 crore and will be paid in cash.

The purchase will happen in two parts, with the first expected by November 2026 and the second by September 2027.

Zettaone designs and builds electronic products for industries such as aerospace, defence, automobiles and medical devices.

Jubilant Ingrevia already makes chemicals used in the semiconductor industry.

It believes Zettaone will help it offer more services across the electronics and semiconductor supply chain.

Zettaone’s CEO said joining the Jubilant Bhartia Group could strengthen its technology business.

Key facts

Acquirer
Jubilant Ingrevia
Target
Zettaone Technologies India
Stake
40%
Deal value
₹189.2 crore
Payment
Cash consideration
Completion timeline
Two tranches: first by November 2026 and second by September 2027
Zettaone FY26 revenue
₹98.1 crore, up from ₹51.1 crore in FY24

Quotes

Harikrishnan Gopal

CEO of Zettaone Technologies

“"We are continuously working towards advancing our strategic priorities and this acquisition is another milestone in our Pinnacle journey. The expertise in high-speed and high-power PCB design and manufacturing of Zettaone Technologies will further anchor our growing Electronics/Semiconductor business with an integrated value proposition to our customers."”
financialexpress.com
“"We are happy to be a part of the Jubilant Bhartia Group, and this development will reinforce our position as a trusted technology partner for mission‑critical electronics solutions in aerospace, defence, semiconductor, auto, medical and industrial spaces."”
financialexpress.com

Sources

Related news